Applied Therapeutics, Inc.

CIK 1697532 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Applied Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 17, 2026SCHEDULE 13G/A0000902664-26-001083
Feb 13, 202615-12G0001193125-26-049942
Feb 6, 2026EFFECT9999999995-26-000461
Feb 6, 2026EFFECT9999999995-26-000463
Feb 4, 202640001193125-26-036963
Feb 3, 2026S-8 POS0001193125-26-035488
Feb 3, 202625-NSE0001354457-26-000130
Feb 3, 202640001193125-26-036176
Feb 3, 202640001193125-26-036198
Feb 3, 202640001193125-26-036128
Feb 3, 202640001193125-26-036147
Feb 3, 2026S-8 POS0001193125-26-035507
Feb 3, 2026POS AM0001193125-26-035528
Feb 3, 202640001193125-26-036133
Feb 3, 2026SC TO-T/A0001193125-26-034514
Feb 3, 2026SC 14D9/A0001193125-26-034545
Feb 3, 2026POS AM0001193125-26-035517
Feb 3, 2026S-8 POS0001193125-26-035465
Feb 3, 20268-K0001193125-26-034559
Feb 3, 2026S-8 POS0001193125-26-035472
Feb 3, 202640001193125-26-036140
Jan 30, 2026SC 14D9/A0001193125-26-030570
Jan 30, 2026SC TO-T/A0001193125-26-030541
Jan 29, 2026SC 14D9/A0001193125-26-028278
Jan 29, 2026SC TO-T/A0001193125-26-028272